RESCON SUMMIT USA 2027

ABOUT THE SUMMIT

2 Days | Expert Speakers | Industry Networking

Inhalation & Respiratory

drug delivery |

Connected Devices

RESCON

RESCON Summit USA 2027 returns to Boston, Massachusetts, on September 28–29, 2027, bringing together pharmaceutical and biotechnology innovators, inhalation scientists, device developers, regulatory specialists, and technology providers advancing the future of respiratory drug delivery.

Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, this focused industry summit connects scientific discovery with product development, engineering, clinical translation, and commercialization. The programme explores established delivery platforms alongside emerging pulmonary and intranasal therapeutics, biologics, RNA-based medicines, sustainable technologies, and digital respiratory solutions.

Through expert-led presentations, practical technical discussions, and purposeful networking, RESCON creates opportunities to exchange knowledge, tackle development challenges, and build collaborations across the respiratory medicines ecosystem.

From formulation science and advanced inhalation devices to connected therapies and commercialization, RESCON brings the right experts together to turn respiratory innovation into real-world progress.

Why attend RESCON 2027

01

Connect with Experts

02

Discover New Science

03

Build Partnerships

04

Exchange Ideas

explore

The scientific priorities for 2027

1. Inhaled Drug Formulation & Product Development
Dry powders, pMDIs, soft mist inhalers and nebulized products: excipient selection, stability, aerosol performance and drug–device compatibility.

2. Advanced Formulations: mRNA, LNPs & Biologics
Pulmonary and intranasal delivery of RNA-based therapeutics, lipid nanoparticles, proteins and peptides, including particle engineering, stability and translation.

3. Next-Generation Inhalation Devices & Combination Products
Inhaler and nebulizer innovation, device engineering, design controls, human factors, risk management and drug–device integration.

4. Sustainable Inhalation & Low-GWP Propellants
New pMDI propellants, reformulation, device compatibility, manufacturing readiness, environmental performance and regulatory considerations.

5. Pulmonary Biopharmaceutics & Predictive Modelling
Aerosol characterization, lung deposition, dissolution, in vitro testing, PBPK modelling, CFD and in vitro–in vivo relationships.

6. Novel Pulmonary & Intranasal Therapeutic Approaches
Targeted respiratory therapies, systemic delivery via the lungs, nasal-to-brain applications, nanomedicines and novel delivery platforms.

7. Connected Inhalers, Digital Health & Smart Devices
Connected nebulizers, adherence monitoring, integrated sensors, patient engagement and real-world data.

8. Regulatory Strategy, Quality & Clinical Development
FDA expectations for OINDPs, bioequivalence, generics, combination product requirements and clinical development strategies.

9. Manufacturing, Scale-Up & Commercialization
Spray drying, particle engineering, process optimization, quality-by-design, technology transfer and commercial-scale production.

experience

More than a conference

Two days of scientific exchange and meaningful interaction — with technical presentations, panel discussions, an exhibition and networking opportunities designed to bring researchers, developers and decision-makers together.

Expert-Led Presentations

Pre-Conference Networking

Industry Panel Discussions

Professional Networking

Technology Exhibition

Conference Dinner & Connections

connect

Who should attend

RESCON is designed for senior leaders, scientists, engineers and specialists from pharmaceutical and biotechnology companies, device manufacturers, research institutions, regulatory organizations and solution providers, including professionals working in:

Respiratory & Inhaled Drug Development
Formulation Science & Particle Engineering
Dry Powder & pMDI Technologies
Pulmonary & Intranasal Delivery
Biologics & RNA Therapeutics
Analytical Development & Aerosol Testing

Inhalation Device Design & Engineering
Combination Product Development
Human Factors & Usability
Connected Devices & Digital Health
Manufacturing, CMC & Scale-Up
Quality, Regulatory Affairs & Compliance

Clinical & Translational Research
Pulmonary Biopharmaceutics
Computational & Predictive Modelling
Generic Inhalation Product Development
Business Development & Partnerships
Technology, Equipment & Services

LET’S ADVANCE RESPIRATORY INNOVATION TOGETHER

Position your organization at the heart of inhalation and respiratory drug delivery. Explore sponsorship, exhibition and strategic partnership opportunities at RESCON Summit USA 2027 in Boston.